These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 82537)

  • 21. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
    Alexander B
    Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500
    [No Abstract]   [Full Text] [Related]  

  • 22. [The anaphylactoid reaction after colloid infusion].
    Ring J
    Fortschr Med; 1977 Nov; 95(41):2481-4. PubMed ID: 72035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood substitutes.
    Kostrzewska E
    Ann R Coll Surg Engl; 1976 Mar; 58(2):115-25. PubMed ID: 57736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation, hemostasis, and plasma expanders:a quarter century enigma.
    Alexander B; Odake K; Lawlor D; Swanger M
    Fed Proc; 1975 May; 34(6):1429-40. PubMed ID: 47813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Perfusion changes in hemodilution. The effect of extensive isovolemic hemodilution with gelatin and hydroxyethylstarch solutions on cerebral blood flow velocity and cutaneous microcirculation in humans].
    Mühling J; Detsch O; Mühling A; Sablotzki A; Dehne MG; Dietrich G; Hempelmann G
    Anaesthesist; 1997 Nov; 46(11):927-37. PubMed ID: 9490579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic blood substitutes: where are we and where do we go from here?
    Miller IF
    CRC Crit Rev Bioeng; 1978; 3(2):149-79. PubMed ID: 83218
    [No Abstract]   [Full Text] [Related]  

  • 27. PE-PEG/LEH can reduce its interactions with plasma expanders indexed through viscosity measurements.
    Chung TW; Huang YY; Wu CI
    Artif Cells Blood Substit Immobil Biotechnol; 1999 May; 27(3):215-27. PubMed ID: 10226685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects and adverse effects of colloid-containing solutions].
    Bergmann H
    Beitr Infusionther Klin Ernahr; 1979; 2():43-50. PubMed ID: 94260
    [No Abstract]   [Full Text] [Related]  

  • 30. The determinants of the efficacy of various expanders in plasma volume expansion and maintenance in normal subjects.
    METCALF W; ROUSSELOT LM; HARMON JM; GILBERTSON FE
    Surg Forum; 1953 Oct; 4():714-9. PubMed ID: 13187372
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.
    Karlson KE; Garzon AA; Shaftan GW; Chu CJ
    Surgery; 1967 Oct; 62(4):670-8. PubMed ID: 6058021
    [No Abstract]   [Full Text] [Related]  

  • 32. Presently useful plasma volume expanders.
    Kliman A
    Anesthesiology; 1966; 27(4):417-24. PubMed ID: 5946521
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of 6% hydroxyethyl starch 130/0.42 and 4% gelatin on renal function in a pediatric animal model.
    Witt L; Glage S; Schulz K; Lichtinghagen R; Simann A; Pape L; Sümpelmann R
    Paediatr Anaesth; 2014 Sep; 24(9):974-9. PubMed ID: 24916275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological findings in infusions of colloidal solutions].
    Richter W; Hedin H; Ring J
    Med Welt; 1977 Oct; 28(42):1717-9. PubMed ID: 73122
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental and clinical study of a plasma expander (hydroxyethyl starch)--comparison with dextran 70 and MF-gelatine].
    Goto Y; Kimura H; Matsumoto K; Yamahara T; Nagata M
    Masui; 1971 Nov; 20(12):1114-23. PubMed ID: 5169830
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma expanders stabilize human microvessels in microfluidic scaffolds.
    Leung AD; Wong KH; Tien J
    J Biomed Mater Res A; 2012 Jul; 100(7):1815-22. PubMed ID: 22489049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Varied circulatory effects after rapid infusion of hydroxyethyl starch, dextran 60 and blood in the postoperative patient].
    Eisele R; Birnbaum D; Büscher D; Kötter D; Nasseri M
    Infusionsther Klin Ernahr; 1979; 6(1):43-8. PubMed ID: 84791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of efficacy of dextran, oxypolygelatin, plasma and saline as plasma volume expanders.
    RAISZ LG; PULASKI EJ
    Am J Physiol; 1952 May; 169(2):475-82. PubMed ID: 14933615
    [No Abstract]   [Full Text] [Related]  

  • 40. [Retention time of colloid-osmotic infusions].
    Halmágyi M
    Beitr Infusionther Klin Ernahr; 1979; 2():51-68. PubMed ID: 94261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.